Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
10x Genomics, Inc.
13G/A
Amendment 4
TXG · 88025U109
|
5.2% |
10/7/2026
Event 9/30/2026
|
|||
| ARK Investment Management LLC | 5.2% | ||||
| Catherine D. Wood | 5.2% | ||||
|
Twist Bioscience Corp
13G/A
Amendment 10
TWST · 90184D100
|
5.1% |
9/8/2026
Event 8/31/2026
|
|||
| ARK Investment Management LLC | 5.1% | ||||
| Catherine D. Wood | 5.1% | ||||
|
10x Genomics, Inc.
13G/A
Amendment 3
TXG · 88025U109
|
8.6% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 8.6% | ||||
| Catherine D. Wood | 8.6% | ||||
|
Twist Bioscience Corp
13G/A
Amendment 9
TWST · 90184D100
|
7.3% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 7.3% | ||||
| Catherine D. Wood | 7.3% | ||||
|
908 Devices Inc.
13G/A
Amendment 9
MASS · 65443P102
|
5.3% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 5.3% | ||||
| Catherine D. Wood | 5.3% | ||||
|
Beam Therapeutics Inc.
13G/A
Amendment 7
BEAM · 07373V105
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 10.0% | ||||
| Catherine D. Wood | 10.0% | ||||
|
Pacific Biosciences of California, Inc.
13G/A
Amendment 7
PACB · 69404D108
|
9.6% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 9.6% | ||||
| Catherine D. Wood | 9.6% | ||||
|
Cerus Corp
13G/A
Amendment 11
CERS · 157085101
|
9.0% |
8/14/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 9.0% | ||||
| Catherine D. Wood | 9.0% | ||||
|
Brera Holdings PLC
13G/A
Amendment 3
BREA · G13311108
|
4.9% |
8/7/2026
Event 7/31/2026
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
GeneDx Holdings Corp.
13G/A
Amendment 1
WGS · 81663L200
|
5.3% |
8/7/2026
Event 7/31/2026
|
|||
| ARK Investment Management LLC | 5.3% | ||||
| Catherine D. Wood | 5.3% | ||||
|
Brera Holdings PLC
13G/A
Amendment 2
BREA · G13311108
|
5.5% |
7/8/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 5.5% | ||||
| Catherine D. Wood | 5.5% | ||||
|
Strata Critical Medical, Inc.
13G/A
Amendment 7
SRTA · 092667104
|
3.2% |
7/8/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 3.2% | ||||
| Catherine D. Wood | 3.2% | ||||
|
Canton Strategic Holdings, Inc.
13G/A
Amendment 1
CNTN · 432705309
|
4.7% |
7/8/2026
Event 6/30/2026
|
|||
| ARK Investment Management LLC | 4.7% | ||||
| Catherine D. Wood | 4.7% | ||||
|
908 Devices Inc.
13G/A
Amendment 8
MASS · 65443P102
|
4.9% |
6/5/2026
Event 5/31/2026
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
Archer Aviation Inc.
13G/A
Amendment 1
ACHR · 03945R102
|
4.9% |
5/7/2026
Event 4/30/2026
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 10
ARCT · 03969T109
|
10.4% |
5/7/2026
Event 4/30/2026
|
|||
| ARK Investment Management LLC | 10.4% | ||||
| Catherine D. Wood | 10.4% | ||||
|
Twist Bioscience Corp
13G/A
Amendment 8
TWST · 90184D100
|
10.4% |
4/30/2026
Event 3/31/2026
|
|||
| ARK Investment Management LLC | 10.4% | ||||
| Catherine D. Wood | 10.4% | ||||
|
Strata Critical Medical, Inc.
13G/A
Amendment 6
SRTA · 092667104
|
8.6% |
4/30/2026
Event 3/31/2026
|
|||
| ARK Investment Management LLC | 8.6% | ||||
| Catherine D. Wood | 8.6% | ||||
|
CRISPR Therapeutics AG
13G/A
Amendment 13
CRSP · H17182108
|
11.8% |
4/30/2026
Event 3/31/2026
|
|||
| ARK Investment Management LLC | 11.8% | ||||
| Catherine D. Wood | 11.8% | ||||
|
Tempus AI, Inc.
13G
TEM · 88023B103
|
5.4% |
3/6/2026
Event 2/28/2026
|
|||
| ARK Investment Management LLC | 5.4% | ||||
| Catherine D. Wood | 5.4% | ||||
|
PagerDuty, Inc.
13G/A
Amendment 11
PD · 69553P100
|
0.2% |
3/6/2026
Event 2/28/2026
|
|||
| ARK Investment Management LLC | 0.2% | ||||
| Catherine D. Wood | 0.2% | ||||
|
Tharimmune, Inc.
13G
CNTN · 432705309
|
8.9% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 8.9% | ||||
| Catherine D. Wood | 8.9% | ||||
|
Recursion Pharmaceuticals, Inc.
13G/A
Amendment 3
RXRX · 75629V104
|
7.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 7.3% | ||||
| Catherine D. Wood | 7.3% | ||||
|
Pacific Biosciences of California, Inc.
13G/A
Amendment 6
PACB · 69404D108
|
12.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 12.3% | ||||
| Catherine D. Wood | 12.3% | ||||
|
Intellia Therapeutics, Inc.
13G/A
Amendment 8
NTLA · 45826J105
|
12.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 12.3% | ||||
| Catherine D. Wood | 12.3% | ||||
|
Beam Therapeutics Inc.
13G/A
Amendment 6
BEAM · 07373V105
|
12.3% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 12.3% | ||||
| Catherine D. Wood | 12.3% | ||||
|
Archer Aviation Inc.
13G
ACHR · 03945R102
|
5.4% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 5.4% | ||||
| Catherine D. Wood | 5.4% | ||||
|
Twist Bioscience Corp
13G/A
Amendment 7
TWST · 90184D100
|
12.4% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 12.4% | ||||
| Catherine D. Wood | 12.4% | ||||
|
Brera Holdings PLC
13G/A
Amendment 1
BREA · G13311108
|
14.4% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 14.4% | ||||
| Catherine D. Wood | 14.4% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 9
ARCT · 03969T109
|
9.2% |
2/3/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 9.2% | ||||
| Catherine D. Wood | 9.2% | ||||
|
Veracyte, Inc.
13G/A
Amendment 1
VCYT · 92337F107
|
4.9% |
1/8/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 4.9% | ||||
| Catherine D. Wood | 4.9% | ||||
|
Roku, Inc
13G/A
Amendment 11
ROKU · 77543R102
|
4.5% |
1/8/2026
Event 12/31/2025
|
|||
| ARK Investment Management LLC | 4.5% | ||||
| Catherine D. Wood | 4.5% | ||||
|
Iridium Communications Inc.
13G/A
Amendment 4
IRDM · 46269C102
|
3.9% |
12/5/2025
Event 11/30/2025
|
|||
| ARK Investment Management LLC | 3.9% | ||||
| Catherine D. Wood | 3.9% | ||||
|
Kodiak AI, Inc.
13G/A
Amendment 1
KDK · 500081104
|
1.2% |
11/7/2025
Event 10/31/2025
|
|||
| ARK Investment Management LLC | 1.2% | ||||
| Catherine D. Wood | 1.2% | ||||
|
Veracyte, Inc.
13G
VCYT · 92337F107
|
5.7% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 5.7% | ||||
| Catherine D. Wood | 5.7% | ||||
|
Strata Critical Medical, Inc.
13G/A
Amendment 5
SRTA · 092667104
|
7.5% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 7.5% | ||||
| Catherine D. Wood | 7.5% | ||||
|
Roku, Inc
13G/A
Amendment 10
ROKU · 77543R102
|
5.6% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 5.6% | ||||
| Catherine D. Wood | 5.6% | ||||
|
PagerDuty, Inc.
13G/A
Amendment 10
PD · 69553P100
|
9.5% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 9.5% | ||||
| Catherine D. Wood | 9.5% | ||||
|
Pacific Biosciences of California, Inc.
13G/A
Amendment 5
PACB · 69404D108
|
10.3% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 10.3% | ||||
| Catherine D. Wood | 10.3% | ||||
|
Kodiak AI, Inc.
13G
KDK · 500081104
|
5.1% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 5.1% | ||||
| Catherine D. Wood | 5.1% | ||||
|
Iridium Communications Inc.
13G/A
Amendment 3
IRDM · 46269C102
|
6.1% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 6.1% | ||||
| Catherine D. Wood | 6.1% | ||||
|
Intellia Therapeutics, Inc.
13G/A
Amendment 7
NTLA · 45826J105
|
11.1% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 11.1% | ||||
| Catherine D. Wood | 11.1% | ||||
|
CRISPR Therapeutics AG
13G/A
Amendment 12
CRSP · H17182108
|
10.8% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 10.8% | ||||
| Catherine D. Wood | 10.8% | ||||
|
908 Devices Inc.
13G/A
Amendment 7
MASS · 65443P102
|
5.4% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 5.4% | ||||
| Catherine D. Wood | 5.4% | ||||
|
10x Genomics, Inc.
13G/A
Amendment 2
TXG · 88025U109
|
10.4% |
11/4/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 10.4% | ||||
| Catherine D. Wood | 10.4% | ||||
|
Brera Holdings PLC
13G
BREA · G13311108
|
11.5% |
10/7/2025
Event 9/30/2025
|
|||
| ARK Investment Management LLC | 11.5% | ||||
| Catherine D. Wood | 11.5% | ||||
|
PagerDuty, Inc.
13G/A
Amendment 9
PD · 69553P100
|
10.9% |
8/7/2025
Event 7/31/2025
|
|||
| ARK Investment Management LLC | 10.9% | ||||
| Catherine D. Wood | 10.9% | ||||
|
Beam Therapeutics Inc.
13G/A
Amendment 5
BEAM · 07373V105
|
10.4% |
8/7/2025
Event 7/31/2025
|
|||
| ARK Investment Management LLC | 10.4% | ||||
| Catherine D. Wood | 10.4% | ||||
|
PagerDuty, Inc.
13G/A
Amendment 8
PD · 69553P100
|
9.3% |
7/30/2025
Event 6/30/2025
|
|||
| ARK Investment Management LLC | 9.3% | ||||
| Catherine D. Wood | 9.3% | ||||
|
Cerus Corp
13G/A
Amendment 10
CERS · 157085101
|
10.1% |
7/30/2025
Event 6/30/2025
|
|||
| ARK Investment Management LLC | 10.1% | ||||
| Catherine D. Wood | 10.1% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 8
ARCT · 03969T109
|
6.3% |
7/30/2025
Event 6/30/2025
|
|||
| ARK Investment Management LLC | 6.3% | ||||
| Catherine D. Wood | 6.3% | ||||
|
Archer Aviation Inc.
13G/A
Amendment 1
ACHR · 03945R102
|
4.6% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 4.6% | ||||
| Catherine D. Wood | 4.6% | ||||
|
Veracyte, Inc.
13G/A
Amendment 1
VCYT · 92337F107
|
4.1% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 4.1% | ||||
| Catherine D. Wood | 4.1% | ||||
|
Quantum-Si Inc
13G/A
Amendment 8
QSI · 74765K105
|
4.8% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 4.8% | ||||
| Catherine D. Wood | 4.8% | ||||
|
Adaptive Biotechnologies Corporation
13G/A
Amendment 1
ADPT · 00650F109
|
2.9% |
6/6/2025
Event 5/31/2025
|
|||
| ARK Investment Management LLC | 2.9% | ||||
| Catherine D. Wood | 2.9% | ||||
|
CRISPR Therapeutics AG
13G/A
Amendment 11
CRSP · H17182108
|
11.9% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 11.9% | ||||
| Catherine D. Wood | 11.9% | ||||
|
10x Genomics, Inc.
13G/A
Amendment 1
TXG · 88025U109
|
11.9% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 11.9% | ||||
| Catherine D. Wood | 11.9% | ||||
|
Roku, Inc
13G/A
Amendment 9
ROKU · 77543R102
|
6.7% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 6.7% | ||||
| Catherine D. Wood | 6.7% | ||||
|
Veracyte, Inc.
13G
VCYT · 92337F107
|
5.1% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 5.1% | ||||
| Catherine D. Wood | 5.1% | ||||
|
Quantum-Si Inc
13G/A
Amendment 7
QSI · 74765K105
|
5.3% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 5.3% | ||||
| Catherine D. Wood | 5.3% | ||||
|
Personalis, Inc.
13G/A
Amendment 7
PSNL · 71535D106
|
8.1% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 8.1% | ||||
| Catherine D. Wood | 8.1% | ||||
|
Archer Aviation Inc.
13G
ACHR · 03945R102
|
5.0% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 5.0% | ||||
| Catherine D. Wood | 5.0% | ||||
|
Accolade, Inc.
13G/A
Amendment 4
ACCD · 00437E102
|
0% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 0% | ||||
| Catherine D. Wood | 0% | ||||
|
Adaptive Biotechnologies Corporation
13G
ADPT · 00650F109
|
5.2% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 5.2% | ||||
| Catherine D. Wood | 5.2% | ||||
|
Absci Corp
13G/A
Amendment 2
ABSI · 00091E109
|
8.6% |
5/14/2025
Event 3/31/2025
|
|||
| ARK Investment Management LLC | 8.6% | ||||
| Catherine D. Wood | 8.6% | ||||
|
Veracyte, Inc.
13G/A
Amendment 10
VCYT · 92337F107
|
4.5% |
5/7/2025
Event 4/30/2025
|
|||
|
Archer Aviation Inc.
13G/A
Amendment 6
ACHR · 03945R102
|
4.8% |
5/7/2025
Event 4/30/2025
|
|||
|
Adaptive Biotechnologies Corporation
13G/A
Amendment 3
ADPT · 00650F109
|
4.0% |
5/7/2025
Event 4/30/2025
|
|||
|
Twist Bioscience Corp
13G/A
Amendment 6
TWST · 90184D100
|
10.7% |
3/7/2025
Event 2/28/2025
|
|||
|
PagerDuty, Inc.
13G/A
Amendment 7
PD · 69553P100
|
10.4% |
3/7/2025
Event 2/28/2025
|
|||
|
CRISPR Therapeutics AG
13G/A
Amendment 10
CRSP · H17182108
|
10.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Repare Therapeutics Inc.
13G/A
Amendment 3
RPTX · 760273102
|
4.7% |
2/14/2025
Event 12/31/2024
|
|||
|
Recursion Pharmaceuticals, Inc.
13G/A
Amendment 2
RXRX · 75629V104
|
8.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Markforged Holding Corp
13G/A
Amendment 6
MKFG · 57064N102
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
Adaptive Biotechnologies Corp
13G/A
Amendment 2
ADPT · 00650F109
|
6.4% |
2/14/2025
Event 12/31/2024
|
|||
|
CareDx, Inc.
13G/A
Amendment 6
CDNA · 14167L103
|
4.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Cerus Corp
13G/A
Amendment 9
CERS · 157085101
|
11.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Personalis, Inc.
13G/A
Amendment 6
PSNL · 71535D106
|
9.6% |
2/14/2025
Event 12/31/2024
|
|||
|
908 Devices Inc.
13G/A
Amendment 6
MASS · 65443P102
|
8.0% |
2/14/2025
Event 12/31/2024
|
|||
|
Quantum-Si Inc
13G/A
Amendment 6
QSI · 74765K105
|
7.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Absci Corp
13G/A
Amendment 1
ABSI · 00091E109
|
7.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Accolade, Inc.
13G/A
Amendment 3
ACCD · 00437E102
|
6.7% |
1/10/2025
Event 9/30/2024
|
|||
|
Butterfly Network, Inc.
13G/A
Amendment 2
BFLY · 124155102
|
4.7% |
1/10/2025
Event 9/30/2024
|
|||
|
CareDx, Inc.
13G/A
Amendment 5
CDNA · 14167L103
|
5.7% |
1/10/2025
Event 9/30/2024
|
|||
|
Beam Therapeutics Inc.
13G/A
Amendment 4
BEAM · 07373V105
|
7.9% |
1/10/2025
Event 9/30/2024
|
|||
|
Archer Aviation Inc.
13G/A
Amendment 5
ACHR · 03945R102
|
7.4% |
1/10/2025
Event 9/30/2024
|
|||
|
Cerus Corp
13G/A
Amendment 8
CERS · 157085101
|
9.8% |
1/10/2025
Event 9/30/2024
|
|||
|
Nurix Therapeutics Inc.
13G/A
Amendment 1
NRIX · 67080M103
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Markforged Holding Corp
13G/A
Amendment 5
MKFG · 57064N102
|
5.8% |
1/10/2025
Event 9/30/2024
|
|||
|
Nextdoor Holdings, Inc.
13G/A
Amendment 2
NXDR · 65345M108
|
3.7% |
1/10/2025
Event 9/30/2024
|
|||
|
Absci Corp
13G
ABSI · 00091E109
|
5.6% |
1/10/2025
Event 9/30/2024
|
|||
|
Vuzix Corp
13G/A
Amendment 5
VUZI · 92921W300
|
3.8% |
1/10/2025
Event 9/30/2024
|
|||
|
Ginkgo Bioworks Holdings, Inc.
13G/A
Amendment 3
DNA · 37611X209
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Velo3D, Inc.
13G/A
Amendment 2
VLD · 92259N104
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Verve Therapeutics, Inc.
13G/A
Amendment 2
VERV · 92539P101
|
0% |
1/10/2025
Event 9/30/2024
|
|||
|
Roku, Inc
13G/A
Amendment 8
ROKU · 77543R102
|
8.8% |
1/10/2025
Event 9/30/2024
|
|||
|
908 Devices Inc.
13G/A
Amendment 5
MASS · 65443P102
|
9.3% |
1/10/2025
Event 9/30/2024
|
|||
|
CRISPR Therapeutics AG
13G/A
Amendment 9
CRSP · H17182108
|
8.8% |
1/10/2025
Event 9/30/2024
|
|||
|
Veracyte, Inc.
13G/A
Amendment 9
VCYT · 92337F107
|
6.4% |
1/10/2025
Event 9/30/2024
|
|||
|
2U, Inc.
13G/A
Amendment 6
TWOU · 90214J101
|
0% |
1/10/2025
Event 9/30/2024
|
|||